Next Article in Journal
Clinical and Economic Evidence Supporting the Value of Fluorescence Imaging of Bacteria in Wound Care
Next Article in Special Issue
EU Joint Clinical Assessment: A Framework for Optimising Use with Cost-Effectiveness Decision-Making
Previous Article in Journal / Special Issue
Shaping the Future of DHT Assessment: Insights on Industry Challenges, Developer Needs, and a Harmonized, European HTA Framework
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JMAHP
Volume 13
Issue 4
10.3390/jmahp13040047
jmahp-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Opinion

Shaping the Future of HTA in Italy: Insights from the Italian Health Policy Forum

by
Paolo Sciattella
1,2,
Roberta Laurita
3,*,
Chiara Bini
1,
Eugenio Di Brino
2,4,
Dario Sacchini
5,6 and
Giandomenico Nollo
6,7
1
Centre for Economics and International Studies-Economic Evaluation and Health Technology Assessment, Faculty of Economics, University of Rome “Tor Vergata”, Via Columbia 2, 00133 Rome, Italy
2
Health Policy Forum, SIHTA (Italian Society of Health Technology Assessment), 00144 Rome, Italy
3
Department of Management, Faculty of Economics, Università Cattolica del Sacro Cuore, Via Necchi, 7, 20123 Milan, Italy
4
ALTEMS, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy
5
Research Center for Clinical Bioethics and Medical Humanities, Department of Healthcare Surveillance and Bioethics, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy
6
Italian Society of Health Technology Assessment (SIHTA), Via Massimo Bontempelli 10, 00144 Rome, Italy
7
Department of Industrial Engineering, University of Trento, Via Sommarive, 9, 38123 Trento, Italy
*
Author to whom correspondence should be addressed.
J. Mark. Access Health Policy 2025, 13(4), 47; https://doi.org/10.3390/jmahp13040047
Submission received: 11 July 2025 / Revised: 8 September 2025 / Accepted: 15 September 2025 / Published: 24 September 2025
(This article belongs to the Collection European Health Technology Assessment (EU HTA))
Versions Notes

Abstract

The implementation of the European (EU) Health Technology Assessment (HTA) Regulation 2021/2282 (EU HTAR) offers many opportunities, aimed at harmonizing HTA procedures and improving access to innovations; it also represents a significant challenge for the European healthcare system. Within the 2024 Health Policy Forum Italy meeting, different actors, stakeholders, and institutions had the opportunity to discuss major criticism and opportunities coming from the EU-HTA Regulation addressing future developments in the healthcare sector. Two groups, EU & Italy Pharmaceuticals and EU-Italy Medical Devices, worked distinctively on the EU HTAR by highlighting key issues that may pose challenges at both European and national levels, proposing potential solutions. The allocation of participants into two groups, according to their affiliation with either the pharmaceutical or the medical device sector, enhances the diversity of professional backgrounds and institutional perspectives, thereby fostering a more comprehensive and informed discussion. The recommendations highlighted by the two groups emphasize the need to promote cooperation among Member States, strengthen training for decision-makers, and develop a monitoring system to evaluate EU HTA’s impact.
Keywords: health technology assessment; EU-HTA Regulation; medical devices; medicinal products health technology assessment; EU-HTA Regulation; medical devices; medicinal products

Share and Cite

MDPI and ACS Style

Sciattella, P.; Laurita, R.; Bini, C.; Di Brino, E.; Sacchini, D.; Nollo, G. Shaping the Future of HTA in Italy: Insights from the Italian Health Policy Forum. J. Mark. Access Health Policy 2025, 13, 47. https://doi.org/10.3390/jmahp13040047

AMA Style

Sciattella P, Laurita R, Bini C, Di Brino E, Sacchini D, Nollo G. Shaping the Future of HTA in Italy: Insights from the Italian Health Policy Forum. Journal of Market Access & Health Policy. 2025; 13(4):47. https://doi.org/10.3390/jmahp13040047

Chicago/Turabian Style

Sciattella, Paolo, Roberta Laurita, Chiara Bini, Eugenio Di Brino, Dario Sacchini, and Giandomenico Nollo. 2025. "Shaping the Future of HTA in Italy: Insights from the Italian Health Policy Forum" Journal of Market Access & Health Policy 13, no. 4: 47. https://doi.org/10.3390/jmahp13040047

APA Style

Sciattella, P., Laurita, R., Bini, C., Di Brino, E., Sacchini, D., & Nollo, G. (2025). Shaping the Future of HTA in Italy: Insights from the Italian Health Policy Forum. Journal of Market Access & Health Policy, 13(4), 47. https://doi.org/10.3390/jmahp13040047

Article Metrics

Back to TopTop